STAMBPL1 and neoplasm: Importantly, we noticed that STAMBPL1 KD contributed to enhancing the sensitivity of sunitinib in these cell lines, while ectopic overexpression of STAMBPL1 increased sunitinib resistance of the tumor cells (Figure 7F,G; Figure S30A,B, Supporting Information).